Duke University Health System (DUHS) — Durham, North Carolina

Duke University Health System (DUHS) is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

Duke University Health System (DUHS) has participated in 4 clinical trials with 3 currently active.

Therapeutic areas: Acute Myeloid Leukemia, Multiple Myeloma, Relapsed/Refractory Multiple Myeloma.

Sponsors: GlycoMimetics Incorporated, Regeneron Pharmaceuticals, Caribou Biosciences, Inc..

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke University Health System (DUHS)?

Duke University Health System (DUHS) has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke University Health System (DUHS) conducted?

Duke University Health System (DUHS) has 4 clinical trials on record, with 3 currently active. Their work covers Acute Myeloid Leukemia, Multiple Myeloma, Relapsed/Refractory Multiple Myeloma.

Is Duke University Health System (DUHS) accredited by Crixeo Health?

Duke University Health System (DUHS) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke University Health System (DUHS)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.